Term
Five main groups of Antifungals |
|
Definition
- Allylamines - Terbinafine, Naftifine
- Azoles-Miconazole, Clotrimazole, Ketoconazole, Itraconazole, Fluconazole, Enilconazole
- Polyenes-Amphotericin B, Nystatin, Natamycin
- Flucytosine (5-FC)
- Griseofulvin
|
|
|
Term
Consistently Fungistatic Drugs |
|
Definition
|
|
Term
Fungistatic/fungicidal Drugs |
|
Definition
- Depends on organisms involved and concentration of drug present
Flucytosine (5-FC)
Allylamines
|
|
|
Term
Consistently fungicidal drug |
|
Definition
|
|
Term
Administration time of Antifungals |
|
Definition
- With exception of polyenes, anti-fungals only fxn vs. replicating fungi (which replicate slowly). So must be administered for a prolonged period of time
|
|
|
Term
Antifungals that inhibit/disrupt cell membrane function/synthesis |
|
Definition
Allylamines
Azoles
Polyenes |
|
|
Term
Antifungals that inhibit nucleic acid synthesis |
|
Definition
Flucytosine (5-FC)
Griseofulvin |
|
|
Term
Criteria for Selection of Antifungals |
|
Definition
- Determining which drug or drug class has activity vs. organism of interest (dermatophytes, moles, and/or yeast)
- Availability of particular drug in desired dosage form
- Relative toxicity of selected drug
|
|
|
Term
|
Definition
Naftifine (Naftin)
Terbinafine (Lamisil) |
|
|
Term
Mechanism of Allylamine Action |
|
Definition
- Following either topical or oral admin, concentrates in nail and skin
- Binds to enzyme that converts squalene to lanosterol (precursor of ergosterol synthesis) --> cell membrane synthesis/function disrupted --> increased permeability such that contents leak out of cell
- ONLY VS REPLICATING FUNGI
|
|
|
Term
Spectrum of Allylamines activity |
|
Definition
Fungicidal vs. dermatophytes
Terbinafine can sometimes be used as fungistatic drug vs. cryptococcus |
|
|
Term
|
Definition
- Following topical/oral admin, concentrates in nails/skin so great for dermatophyte infections (Metabo in liver so if PO, must be monitered by blood)
- Terbinafine occasionally used for crypto infections
|
|
|
Term
Adverse effects of Allylamines |
|
Definition
Since allylamines target fungal-specific enzyme, neither topical/oral admin results in significant adverse effects. However, liver metabolism, so must check blood for liver function if given PO |
|
|
Term
|
Definition
- Miconazole (Monistat): Topical
- Clotrimazole: Topical
- Enilconazole: Topical
- Ketoconazole (Nizoral): Topical/Oral - Mod distribution - hepatic metabolism
- Itraconazole (Sporanox): Topical/Oral - Mod distribution - hepatic metabolism
- Fuconazole (Diflucan): Oral/IV - Excellent distribution Excreted Unchanged in urine
|
|
|
Term
Mechanism of Azole Activity
|
|
Definition
- Azole binds to enzyme that converts lanosterol to ergosterol --> disruption of cell membrane synthesis/function --> Increased cell permeability and leaking of cell contents
- FUNGISTATIC only effective vs. REPLICATING cells
|
|
|
Term
Spectrum of Azoles Activity |
|
Definition
- Dermatophytes
- Yeasts (Blastomyces dermatitidis, Histoplasma capsulatum, Cryptococcus neoformans, Candida, Coccidioides immitis, Sporothrix schenkii, Malassezia)
- Molds (Aspergillus)
**Broad Spectrum** |
|
|
Term
|
Definition
- Topically for treatment of eye, skin, and vaginal fungal infections
- Dermatophyte infections, Mycotic otitis externa (Malassezia), Equine fungal keratitis (Aspergillus), Guttural pouch mycosis (Aspergillus), Vaginitis (Candida)
- PO for systemic fungal infections (Cryptococcosis, histoplasmosis, coccidiomycosis, blastomycosis, aspergillosis)
|
|
|
Term
Adverse Effects of Azoles |
|
Definition
- Clotrimazole, miconazole, and enilconazole very toxic so only use topically (No adverse effects if topical)
- Systemic admin of ketoconazole and itraconazole = hepatotoxis, teratogenic/carcinogenic. Only PO
- Fluconazole excreted unchanged in urine, so few if any adverse effects. Therefore, IV and PO.
|
|
|
Term
|
Definition
Amphotericin B (Fungizone) Natamycin Nystatin (Panalog) |
|
|
Term
Mechanism of Polyene Activity |
|
Definition
- Do not penetrate tissues well, so must administerdirectly to site of infection (IV or intrathecal for systemic fungal infections)
- Polyenes bind ergosterol and interact with the fungal cell membrane to form a pore in the cell membrane --> Intracellular potassium, nutrients, etc... leak out and the internal osmotic pressure is not maintained. Damage is irreversible so the cell dies.
**FUNGICIDAL and affects both Growing and Stationary phase fungi**
|
|
|
Term
Spectrum of Activity for Polyenes
|
|
Definition
- Molds: Aspergillus
- Dermatophytes
- Yeasts: Blastomyces dermatitidis, Histoplasma capsulatum, Cryptococcus neoformans, Candida, Coccidioides immitis, Sporothrix schenkii, Malassezia
- Algae: Prototheca spp
- Protozoa: Leishmania sp, Naegleria fowleri
|
|
|
Term
|
Definition
- Primarily topical applications
- IN for guttural pouch mycosis (Aspergillus)
- Oral for thrush
- Topically for mycotic keratitis (Aspergillus)
- Topically for otitis externa in dogs (Malassezia sp)
- Topically for dermatophyte infections (Microsporum, Tichophyton)
- Rarely systemic fungal infections
- IV/intrathecal: cryptococcosis, histoplasmosis, coccidiomycosis, blastomycosis, aspergillosis
- Nystatin used topically and orally (for GI fungal infections). Natamycin only topically (Equine fungal keratitis) Very insoluble and can be used topically without systemic adverse effects.
- Amphotericin B is used topically and only one to be used IV. In human med, used to treat systemic fungal infections and Naegleriosis. Rarely in vet med due to side effects
|
|
|
Term
Amphotericin B is often combined with ____ b/c _____ |
|
Definition
Fluconazole or Flucytosine (5-FC)
Synergistic activity as well as ability to reduce dose and minimize adverse effects |
|
|
Term
Adverse effects of Polyenes |
|
Definition
- None if given topically
- Systemic admin of amphotericin B due to cross-reactivity with cholesterol:
- Nephrotoxicity: associated with binding of distal renal tubular cells and vascular sm mm cells. Must monitor patient renal function
- Hepatotoxicity
- Neurotoxicity: During IV infusion, may exhibit fever, vomiting, depression, and severe shaking
- Thrombophelbitis
|
|
|
Term
Brand name for Flucytosine (5-FC) |
|
Definition
|
|
Term
Mechanism of flucytosine (5-FC) Action |
|
Definition
- Flucytosine (5-FC) is structural analogue of cytosine (which can be converted to uracil as well)
- Taken up by fungal cells via cytosine permease, which normally works to scavange cytosine. Upon uptake 5-FC deaminated to 5-fluorouracil by cytosine deaminase. 5-fluorouracil is converted to 50fluorouridine monophosphate (F-dUMP) and fluorouridine triphosphate (F-UTP)
- F-dUMP cannot be converted by thymidylate synthetase into dTMP, so DNA synthesis blocked
- F-UTP competes with uracil for incorporation into RNA. mRNA containing fluorouracil instead of uracil cannot be translated for protein synthesis
**ONLY WORKS with fungi that have cytosine permease and cytosine deaminase (Cryptococcus, Aspergillus, and Candida). AND ONLY WORKS vs. replicating fungi**
***Usually fungistatic, but can be fungicidal***
|
|
|
Term
Spectrum of Flucytosine (5-FC) Activity |
|
Definition
- Yeasts - Cryptococcus and Candida
- Molds: Aspergillus
**ONLY replicating/growing fungi that have cytosine permease and cytosine deaminase** |
|
|
Term
Use for Flucytosine (5-FC) |
|
Definition
- Orally for treatment of systemic cryptococcosis, candidiasis, or aspergillosis (rarely used due to expense).
- Admin in combo with azole (fluconazole, itraconazole) or Amphotericin B
- So expensive rarely used
|
|
|
Term
Pharmacokinetics and Adverse Effects of Flucytosine (5-FC) |
|
Definition
- Only administered PO: well-absorbed and distributed and penetrates virtulaly all tissues
- Excreted unchanged in the urine
- Targets fungal enzymes, so few, if any adverse effects: nausea, vomiting, rashes common
|
|
|
Term
Resistance to Flucytosine (5-FC) |
|
Definition
- Readily occurs: Loss or decreased activity of cytosine permease, cytosine deaminase, and/or uridine pyrophosphorylase
- Due to easy resistance developments, ususaly used wtih amphotericin B or one of the azoles (itraconazole, fluconazole).
- Combo with amphotericin B synergistic b/c amphotericin B increases fungal permeability. Also allows for lowering of amphotericin B dosage
|
|
|
Term
Brand Name for Griseofulvin |
|
Definition
|
|
Term
Spectrum of activity for Griseofulvin |
|
Definition
|
|
Term
Mechanism of Griseofulvin Action |
|
Definition
- MUST be given PO because topical application does not penetrate to deeper layers of skin
- Absorption from GIT enhanced by using smaller particle sizes and administering with a fatty meal. Will concentrate in keratinized tissue
- Binds microtubules
- Inhibits mitotic spindle formation during cell division such that DNA replication and cell division during metaphase are blocked
- May also damage DNA such that it is unable to replicate (fungicidial)
- Results in inhibition of hyphae formation (fungistatic)
- Concentrates in basal cells of epidermis and carried with them as they mature and form barrier to further hyphal penetration.
**ONLY vs. growing/replicating cells --> Infection eradicated only after keratinized structures are shed and replaced by uninfected tissue. Treatment is very slow process. Clip hair/nail to speed up **
|
|
|
Term
Adverse Effects of Griseofulvin |
|
Definition
- Teratogenicity (cleft palate, skeletal and brain malformation in kittens). DO NOT GIVE to pregnant animals
- Carcinogenicity (Cross-reacts with mammalian microtubules). DO NOT GIVE to food animals
- GI upset (Nausea, vomiting, diarrhea). GIVE WITH FOOD.
- Inhibits spermatogenesis
|
|
|